Clinical value of magnetic resonance imaging in identifying multiple cerebral gliomas from primary central nervous system lymphoma

Chen,Yushan; Zhan,Alai

doi:10.3892/ol.2019.10352

Clinical value of magnetic resonance imaging in identifying multiple cerebral gliomas from primary central nervous system lymphoma

Authors:
- Yushan Chen
- Alai Zhan
View Affiliations

Affiliations: Department of Radiology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian 363000, P.R. China
Published online on: May 13, 2019 https://doi.org/10.3892/ol.2019.10352
Pages: 593-598
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Clinical value of magnetic resonance imaging (MRI) in identifying and diagnosing multiple cerebral glioma (MCG) from primary central nervous system lymphoma (PCNSL) was evaluated. A total of 21 patients with MCG diagnosed clinically and pathologically in Zhangzhou Municipal Hospital from March 2016 to April 2017 were selected as group A, and 30 patients with PCNSL diagnosed in Zhangzhou Affiliated Hospital of Fujian Medical University during the same period as group B. Plain MRI, enhanced MRI and diffusion weighted imaging (DWI) were performed in all patients, the apparent diffusion coefficient (ADC) value of lesions was measured, and the diagnostic efficacy of ADC for MCG and PCNSL was evaluated by receiver operating characteristic (ROC) curve. The incidence of hippocampus lesions, patchy and cystic lesions, and the heterogeneous signal of plain scan in group A was significantly higher than that in group B (P<0.05), and the incidence of basal ganglia lesions was significantly lower than that in group B (P<0.05). Mass lesions in group A were significantly less than those in group B (P<0.05). The ADC value of lesions in group A was significantly higher than that in contralateral normal white matter (P<0.05), the ADC value in group B was significantly lower than that in normal contralateral white matter (P<0.05), so the ADC value in group A was significantly higher than that in group B (P<0.05). The location, lesion shape and signal characteristic of MCG and PCNSL have their own specificity; there are significant differences in DWI signal and ADC color map signal intensity of the lesions; ADC has certain diagnostic value for MCG and PCNSL; the differential diagnosis of MCG from PCNSL by MRI is of great significance.

View Figures

View References

1	Salvati M, Caroli E, Orlando ER, Frati A, Artizzu S and Ferrante L: Multicentric glioma: our experience in 25 patients and critical review of the literature. Neurosurg Rev. 26:275–279. 2003. View Article : Google Scholar : PubMed/NCBI
2	Yin L and Zhang L: Correlation between MRI findings and histological diagnosis of brainstem glioma. Can J Neurol Sci. 40:348–354. 2013. View Article : Google Scholar : PubMed/NCBI
3	Nakhl F, Chang EM, Shiau JS, Alastra A, Wrzolek M, Odaimi M, Raden M and Juliano JE: A patient with multiple synchronous gliomas of distinctly different grades and correlative radiographic findings. Surg Neurol Int. 1:482010. View Article : Google Scholar : PubMed/NCBI
4	di Russo P, Perrini P, Pasqualetti F, Meola A and Vannozzi R: Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature. Acta Neurochir (Wien). 155:2245–2251. 2013. View Article : Google Scholar : PubMed/NCBI
5	Nassiri M, Byrne GE, Whitcomb CC and Byrnes JJ: Synchronous null-cell anaplastic large cell lymphoma and multiple myeloma. Ann Hematol. 88:923–925. 2009. View Article : Google Scholar : PubMed/NCBI
6	Fine HA and Mayer RJ: Primary central nervous system lymphoma. Ann Intern Med. 119:1093–1104. 1993. View Article : Google Scholar : PubMed/NCBI
7	Viaccoz A, Ducray F, Tholance Y, Barcelos GK, Thomas-Maisonneuve L, Ghesquières H, Meyronet D, Quadrio I, Cartalat-Carel S, Louis-Tisserand G, et al: CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma. Neuro Oncol. 17:1497–1503. 2015. View Article : Google Scholar : PubMed/NCBI
8	Hoang-Xuan K, Bessell E, Bromberg J, Hottinger AF, Preusser M, Rudà R, Schlegel U, Siegal T, Soussain C, Abacioglu U, et al European Association for Neuro-Oncology Task Force on Primary CNS Lymphoma, : Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 16:e322–e332. 2015. View Article : Google Scholar : PubMed/NCBI
9	Wang K, Zhao X, Chen Q, Fan D, Qiao Z, Lin S, Jiang T, Dai J and Ai L: A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images. Medicine (Baltimore). 96:e77562017. View Article : Google Scholar : PubMed/NCBI
10	Nagashima H, Sasayama T, Tanaka K, Kyotani K, Sato N, Maeyama M, Kohta M, Sakata J, Yamamoto Y, Hosoda K, et al: Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma. J Neurooncol. 136:317–326. 2018. View Article : Google Scholar : PubMed/NCBI
11	Huang J, Yu J and Peng Y: Association between dynamic contrast enhanced MRI imaging features and WHO histopathological grade in patients with invasive ductal breast cancer. Oncol Lett. 11:3522–3526. 2016. View Article : Google Scholar : PubMed/NCBI
12	Sugita Y, Muta H, Ohshima K, Morioka M, Tsukamoto Y, Takahashi H and Kakita A: Primary central nervous system lymphomas and related diseases: Pathological characteristics and discussion of the differential diagnosis. Neuropathology. 36:313–324. 2016. View Article : Google Scholar : PubMed/NCBI
13	Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, et al International Extranodal Lymphoma Study Group (IELSG), : High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet. 374:1512–1520. 2009. View Article : Google Scholar : PubMed/NCBI
14	Lee JS, Jung TY, Lee KH and Kim SK: Primary central nervous system vasculitis mimicking a cortical brain tumor: a case report. Brain Tumor Res Treat. 5:30–33. 2017. View Article : Google Scholar : PubMed/NCBI
15	Weller RO, Galea I, Carare RO and Minagar A: Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis. Pathophysiology. 17:295–306. 2010. View Article : Google Scholar : PubMed/NCBI
16	Hartmann M, Heiland S, Harting I, Tronnier VM, Sommer C, Ludwig R and Sartor K: Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett. 338:119–122. 2003. View Article : Google Scholar : PubMed/NCBI
17	Haldorsen IS, Espeland A and Larsson EM: Central nervous system lymphoma: Characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 32:984–992. 2011. View Article : Google Scholar : PubMed/NCBI
18	Rojiani AM and Dorovini-Zis K: Glomeruloid vascular structures in glioblastoma multiforme: an immunohistochemical and ultrastructural study. J Neurosurg. 85:1078–1084. 1996. View Article : Google Scholar : PubMed/NCBI
19	Fraser E, Gruenberg K and Rubenstein JL: New approaches in primary central nervous system lymphoma. Chin Clin Oncol. 4:112015.PubMed/NCBI
20	Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, Wakasa K and Yamada R: The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol. 22:1081–1088. 2001.PubMed/NCBI
21	Koubska E, Weichet J and Malikova H: Central nervous system lymphoma: a morphological MRI study. Neuro Endocrinol Lett. 37:318–324. 2016.PubMed/NCBI
22	Guo AC, Cummings TJ, Dash RC and Provenzale JM: Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 224:177–183. 2002. View Article : Google Scholar : PubMed/NCBI
23	Choi YS, Lee HJ, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH and Lee SK: Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient. Eur Radiol. 27:1344–1351. 2017. View Article : Google Scholar : PubMed/NCBI
24	Gadda D, Mazzoni LN, Pasquini L, Busoni S, Simonelli P and Giordano GP: Relationship between apparent diffusion coefficients and MR spectroscopy findings in high-grade gliomas. J Neuroimaging. 27:128–134. 2017. View Article : Google Scholar : PubMed/NCBI
25	Ahn SJ, Shin HJ, Chang JH and Lee SK: Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: Comparison of three different ROI methods. PLoS One. 9:e1129482014. View Article : Google Scholar : PubMed/NCBI